Antibody conjugates

Patent metadata

Field	Value
Publication number	US-11359185-B2
Application number	US-201615064792-A
Country	US
Kind code	B2
Filing date	Mar 9, 2016
Priority date	Apr 28, 2005
Publication date	Jun 14, 2022
Grant date	Jun 14, 2022

Abstract

Antibody/signal-generating moiety conjugates are disclosed that include an antibody covalently linked to a signal-generating moiety through a heterobifunctional polyalkyleneglycol linker. The disclosed conjugates show exceptional signal-generation in immunohistochemical and in situ hybridization assays on tissue sections and cytology samples. In one embodiment, enzyme-metallographic detection of nucleic acid sequences with hapten-labeled probes can be accomplished using the disclosed conjugates as a primary antibody without amplification.

First claim

We claim:

1. A conjugate having the structure

wherein Ab is an intact antibody, SM is a signal-generating moiety, n ranges from 1 to 50, and s ranges from 1 to 10, and wherein the intact antibody comprises two heavy chains and two light chains; wherein the two heavy chains are covalently coupled to each other through at least one inerchain disulfide bond, and wherein the sulfur atom of the construct is derived from a reduced disulfide bond of the antibody.

2. The conjugate of claim 1 , wherein the signal-generating moiety comprises an enzyme.

3. The conjugate of claim 1 , wherein the enzyme is selected from the group consisting of horseradish peroxidase and alkaline phosphatase.

4. The conjugate of claim 1 , wherein s ranges from 2 to 6.

5. The conjugate of claim 1 , wherein n ranges from 4 to 12.

6. The conjugate of claim 1 , wherein n ranges from 4 to 12 and s ranges from 3 to 10.

7. A conjugate comprising at least one intact antibody and at least one enzyme signal-generating moiety, wherein the at least one intact antibody is directly coupled to the at least one enzyme-signal generating moiety through a heterobifunctional PEG linker, the heterobifunctional PEG linker including a thiol reactive group and an amine reactive group, wherein the thiol-reactive group of the heterobifunctional PEG linker is covalently bonded to the at least one intact antibody via a thiol group derived from a reduced disulfide bond of the antibody and the amine-reactive group of the heterobifunctional linker is covalently bonded to the at least one signal-generating moiety, wherein the intact antibody comprises two heavy chains and two light chains and wherein the two heavy chains are covalently coupled to each other through at least one inerchain disulfide bond.

8. The conjugate of claim 7 , wherein the thiol-reactive group is a maleimide and the amine-reactive group is an ester.

9. The conjugate of claim 7 , wherein the at least one antibody is coupled to at least three enzyme-signal generating moieties.

10. The conjugate of claim 7 , where the at least one antibody is coupled to 3 to 6 enzyme-signal generating moieties.

11. The conjugate of claim 7 , wherein the at least one enzyme signal-generating moiety is an alkaline phosphatase.

12. The conjugate of claim 7 , wherein the at least one enzyme signal-generating moiety is horseradish peroxidase.

13. The conjugate of claim 7 , wherein an average molecular weight of the conjugate ranges from about 230 kDa to about 300 kDa.

14. The conjugate of claim 1 , wherein the intact antibody has a molecular weight of about 150,000 g/mol.

15. The conjugate of claim 1 , wherein SM is an enzyme selected from the group consisting of horseradish peroxidase and alkaline phosphatase, and wherein s ranges from 2 to 6.

Assignees

• Ventana Med Syst Inc

Inventors

• Bieniarz Christopher
• Kosmeder Jerome W
• Lefever Mark
• Kernag Casey A
• Ashworth-Sharpe Julia
• Wong Jennifer

Classifications

• G01N33/535

  with enzyme label {or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates} · CPC title

• C12N9/16 Primary

  acting on ester bonds (3.1) · CPC title

• A61K47/65

  Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers · CPC title

• C07K2317/76

  Antagonist effect on antigen, e.g. neutralization or inhibition of binding · CPC title

• C12N9/96

  Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates · CPC title